enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Insomnia: What Exactly Is It & How Do I Treat It? - AOL

   www.aol.com/insomnia-exactly-treat-125700471.html

   Several types of drugs are approved by the FDA (U.S. Food and Drug Administration) for the treatment of insomnia. You may hear many of these commonly referred to as “sleeping pills,” and they ...

3. Somnifacient - Wikipedia

   en.wikipedia.org/wiki/Somnifacient

   Somnifacient (from Latin somnus, sleep [1]), also known as sedatives or sleeping pills, is a class of medications that induces sleep. It is mainly used for treatment of insomnia. Examples of somnifacients include benzodiazepines, barbiturates and antihistamines. Around 2-6% of adults with insomnia use somnifacients to aid sleep. [2]

4. Ramelteon - Wikipedia

   en.wikipedia.org/wiki/Ramelteon

   Ramelteon, sold under the brand name Rozerem among others, is a melatonin agonist medication which is used in the treatment of insomnia. [3] [5] It is indicated specifically for the treatment of insomnia characterized by difficulties with sleep onset. [3] It reduces the time taken to fall asleep, but the degree of clinical benefit is small. [6]

5. The Best Way to Treat Insomnia - AOL

   www.aol.com/best-way-treat-insomnia-160705363.html

   A role for medication. Clinical practice guidelines from the American Academy of Sleep Medicine consistently recommend CBT-I as the first-line treatment for chronic insomnia. “There are multiple ...

6. Doxylamine - Wikipedia

   en.wikipedia.org/wiki/Doxylamine

   The first-generation sedating antihistamines diphenhydramine, doxepin, doxylamine, and pyrilamine are the most widely used medications in the world for preventing and treating insomnia. [6] As of 2004, doxylamine and diphenhydramine, which are both over-the-counter medications, were the agents most commonly used to treat short-term insomnia. [11]

7. Lemborexant - Wikipedia

   en.wikipedia.org/wiki/Lemborexant

   Lemborexant is used in the treatment of insomnia in adults. [3]A major systematic review and network meta-analysis of medications for the treatment of insomnia published in 2022 found that lemborexant had an effect size (standardized mean difference (SMD)) against placebo for treatment of insomnia at 4 weeks of 0.36 (95% CI Tooltip confidence interval 0.08 to 0.63) and at 3 months of 0.41 (95% ...